National Partnership Agreement on Essential Vaccines
Paragraph 40 of the National Partnership Agreement on Essential Vaccines specifies that the COAG Reform Council (CRC)will annually assess the performance of each State and Territory against the improvement areas referred to in Clause 35(b) of the agreement and subject to the detailed arrangements in Schedule F.
In April 2010, the CRC requested the Steering Committee for the Review of Government Service Provision to collate performance information for the agreement. In accordance with the principals of transparency and public accountability outlined in the Intergovernmental Agreement on Federal Financial Relations, the Steering Committee publishes the performance information it provided to the CRC following the public release of the CRCs assessment report.
The CRC ceased operations in mid-2014.
The Steering Committee's performance reports are available below.
Download the reports
1 April 2009 - 31 March 2010
- National Partnership Agreement on Essential Vaccines - 1 April 2009 to 31 March 2010 Performance Report (PDF - 214 Kb)
- National Partnership Agreement on Essential Vaccines - 1 April 2009 to 31 March 2010 Performance Report (Word - 386 Kb)
1 April 2010 - 31 March 2011
- National Partnership Agreement on Essential Vaccines - 1 April 2010 to 31 March 2011 Performance Report (PDF - 304 Kb)
- National Partnership Agreement on Essential Vaccines - 1 April 2010 to 31 March 2011 Performance Report (Word - 274 Kb)
1 April 2011 - 31 March 2012
- National Partnership Agreement on Essential Vaccines - 1 April 2011 to 31 March 2012 Performance Report (PDF - 511 Kb)
- National Partnership Agreement on Essential Vaccines - 1 April 2011 to 31 March 2012 Performance Report (Word - 314 Kb)
1 April 2012 - 31 March 2013
- National Partnership Agreement on Essential Vaccines - 1 April 2012 to 31 March 2013 Performance Report (PDF - 1138 Kb)
- National Partnership Agreement on Essential Vaccines - 1 April 2012 to 31 March 2013 Performance Report (Word - 164 Kb)
The following reports assess the performance of State and Territory governments against the four benchmarks associated with reward payments in the National Partnership Agreement on Essential Vaccines (NP). The four benchmarks are:
- Benchmark 1: maintaining or increasing vaccine coverage for Indigenous Australians
- Benchmark 2: maintaining or increasing coverage in agreed areas of low immunisation coverage
- Benchmark 3: maintaining or decreasing wastage and leakage
- Benchmark 4: maintaining or increasing vaccination coverage for four year olds.
The Productivity Commission's role is to provide an independent assessment to the Council of Australian Governments (COAG) on whether States and Territories have achieved the performance benchmarks in the NP.
The assessment is provided to COAG before reward payments are made. The Productivity Commission does not recommend whether payments should be made under the NP.
National Partnership Agreement on Essential Vaccines 2013-2014
This report assesses the performance of State and Territory government against the four benchmarks set out in the National Partnership Agreement on Essential Vaccines for the period 1 April 2013 to 31 March 2014.
National Partnership Agreement on Essential Vaccines 2014-2015
This report assesses the performance of State and Territory government against the four benchmarks set out in the National Partnership Agreement on Essential Vaccines for the period 1 April 2014 to 31 March 2015.
National Partnership Agreement on Essential Vaccines 2015-2016
This report assesses the performance of State and Territory government against the four benchmarks set out in the National Partnership Agreement on Essential Vaccines for the period 1 April 2015 to 31 March 2016.
National Partnership Agreement on Essential Vaccines 2016-2017
This report assesses the performance of State and Territory government against the four benchmarks set out in the National Partnership Agreement on Essential Vaccines for the period 1 April 2016 to 31 March 2017.